Daisy Bray advises on regulatory matters for pharmaceutical and medical device clients. She advises on the boundaries of the ABPI and EFPIA Codes of Practice and UK and EU legislation in relation to numerous issues throughout a product life cycle including clinical research, advertising and promotion, authorisation, use of social media and marketing materials.

Ms. Bray provides regulatory compliance advice, assisting with product-related investigations. She also assists clients with public and administrative law litigations, arising from the decisions of regulatory bodies such as the Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA). Daisy also assists clients with public inquiries.

Ms. Bray has been seconded to a global pharmaceutical company where she advised on a broad range of commercial matters including investigator driven study agreements, collaborative research agreements, tendering contracts and digital projects.


  • Legal Practice Course, BPP University, 2017, Distinction
  • Graduate Diploma in Law, BPP University, 2015, Commendation
  • BSc, Biomedical Sciences, Newcastle University, 2013, First Class Honors
  • England and Wales

Email Disclaimer